Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · Available online 23 Jun 2026 · In press · DOI 10.1177/1540658x261460558

Authors (6)

Jiajun Huang, Chaohong Da, Shengrui Zhai, Xingyan Yao, Meiling Zhang, Tao Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Huang, J., Da, C., Zhai, S., et al. (2026). Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES. https://doi.org/10.1177/1540658x261460558

Related articles

• Identification of Selective Small Molecule Modulators of mRNA Processing Using a Multiplexed QuantiGene High-Throughput Screening Platform · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Neprilysin Inhibitor and Angiotensin Receptor Blocker Attenuate Ischemic Brain Injury: Unveiling the Kinin-Mediated Pathway · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2026 · Same journal
• Precision Targeting in Gastric Cancer: AI-Driven Discovery of MET, ADORA2A, CDK5R1, and ADORA1 · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Decoding Cholesterol Metabolic Regulation by Naotai Formula in Stroke Management: An Integrated Network Pharmacology and Mendelian Randomization Approach · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2026 · Same journal
• Letter: New Horizons in Biomarker Discovery: Assay Technologies for Personalized Drug Development · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Identification of Potential Molecular Targets of Doxorubicin for Application in Skin Cancer: A Network Pharmacology and Molecular Docking Perspective · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Advances in Capsaicin-Based Nanocarriers: Bridging Mechanistic Insights with Therapeutic Potential and Clinical Outcomes · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Elucidating Genetic and Immunological Pathways Mediated by Sodium-Glucose Transporter 2 Inhibitors in Reducing Gout Risk: A Two-Step Mendelian Randomization Study · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Ultrafast Detection of Environmental Pollutants and Pharmaceutical Residues Using a CuFe Nanozyme-Enhanced Sensing Platform · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Future Prospects and Regulatory Pathways for Invasome Technologies in Transdermal Drug Delivery · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal